ALK and lung cancer: The present case provides three noteworthy observations: (1) a patient with oligoprogressive ALK-positive lung cancer managed aggressively with targeted therapy, SBRT, and surgery had no radiographic evidence of disease more than seven years from diagnosis of stage IV lung cancer, (2) salvage resection was undertaken albeit with challenges in dissection, and (3) the patient subsequently developed a delayed BPF.